HONOUR TO NNE'S ARCHITECTS

Main Menu | News By Date | News By Supplier | News By Category | About Us

HONOUR TO NNE'S ARCHITECTS
03 November 2003 - NNE A/S

The world's largest insulin plant, which NNE built for Novo Nordisk, was awarded a prize for its architecture by the Municipality of Kalundborg at a ceremony on 30 October 2003.

The award committee led by the major of Kalundborg, Mr. Tommy Dinesen, gives the following reasons for awarding the prize:

- The balanced architectural harmony and technical character, illustrates a delicate overall impression between the chemical production and the architectural expression of the plant.

In addition to the major, the award committee counts architect Jørgen Dinesen, architect Bent Falk, the City and Land Society of Kalundborg, architect Egon Fruelund, and architechtural journalist Henrik Sten Møller.

The prize included a plaquette and a diploma for the builder, Novo Nordisk.

The 32,000 m2 Insulin Bulk Plant was inaugurated in June 2003, just two years after ground breaking. The plant is often called a 'superhighway' reflecting the long production building containing all manufacturing processes, from fermentation in one end to finished insulin chrystals in the other.

http://nne.dk/

About: NNE A/S
With more than 80 years of experience, the engineering company NNE is a leading supplier of systems, consultancy and engineering services to the international pharmaceutical and biotechnological industry.

Our competencies span all technical disciplines applying to engineering, construction, validation, start-up and optimisation, and reconstruction of facilities for product development and production plants, pilot plants and laboratories within the pharmaceutical and biotechnological field.

Our unmistakable, clear client focus, combined with a flexible and integrated organisation where engineers, architects and pharmacists work closely together, puts us in a position to deliver customised solutions, ranging from stand-alone services to turnkey plants - quickly and safely.

NNE operates at an international level. We have worked on and completed a large number of projects both in Denmark and the rest of Scandinavia, and we have constructed biotechnological and pharmaceutical production facilities in USA, China, Japan, Brazil, and France.

More News:
  • For November 2003
  • From NNE A/S
  • For Medical Equipment